Supply of Components. FAULDING shall be responsible for the supply of all components in accordance with Schedules I and II hereto; provided that the supply of components shall be exclusively from such suppliers and in such grades as have been approved in writing by CUMBERLAND as reflected on an approved list to be attached hereto as Schedule III, and provided further that such suppliers and grades may not be changed without CUMBERLAND’s prior written consent.
Supply of Components. BIONICHE shall be responsible for the supply of all Buffer Solution, Excipients, and all other components of the finished Drug Product in accordance with Schedules I and II hereto; provided that the supply of these components shall be exclusively from such suppliers and in such grades as have been approved in writing by CUMBERLAND as reflected on an approved list to be attached hereto as Schedule IV, and provided further that such suppliers and grades may not be changed without CUMBERLAND’s prior written consent which consent shall not be unreasonably withheld or delayed. BIONICHE shall maintain, at its expense, secure storage areas for the Buffer Solution, Excipients, and all other components at the Facility.
Supply of Components. You may order Components from us (or, in our discretion, from our wholly-owned subsidiary, Atheros Technology Ltd., a Bermuda corporation), at the then-current Component list prices or such price as is quoted to you in a written price quote. All orders are subject to acceptance, and will be governed by the terms of Exhibit C. Those terms may be modified or supplemented only as provided in Exhibit C. The terms and conditions appearing on any purchase order, invoice or other document submitted by either party will not apply to your order, except for name(s) of product(s) ordered, quantity, requested shipment date and delivery destination. Subject to our prior written consent, which consent may be provided via email, you may authorize third parties such as contract manufacturers to order Components on your behalf. You may not reveal pricing to the third party, and you guarantee payment and compliance by such third party under and with the provisions of Exhibit C.
Supply of Components. You may order Components from us (or, in our discretion, from our wholly-owned subsidiary, Atheros Technology Ltd., a Bermuda corporation), at the then-current Component list prices or such price as is quoted to you in a written price quote. All orders are subject to acceptance, and will be governed by the then-current terms and conditions of sale of Atheros or Atheros Technology Ltd., as applicable. The terms and conditions appearing on any purchase order or other document submitted by you will not apply to your order, except for name(s) of product(s) ordered, quantity, requested shipment date and delivery destination. Subject to our prior written consent, which consent may be provided via email, you may authorize third parties such as contract manufacturers to order Components on your behalf. You may not reveal pricing to the third party, and you guarantee payment and compliance by such third party under and with the then-current terms and conditions of sale of Atheros or Atheros Technology Ltd., as applicable.
Supply of Components. 4.1 Components supplied by PFDC ("PFDC Components")
4.1.1 All PFDC Components remain the property of PFDC and shall be supplied to PFI at no cost to PFI. PFI undertakes not to use such PFDC Components for any purposes other than Production of Products ordered by PFDC. PFDC shall ensure that PFI shall have all PFDC Components necessary to permit PFI to manufacture at least five (5) months of Production (i.e., firm orders over the applicable three (3) month period and forecasts for the two (2) following months).
4.1.2 Promptly, but in any event no later than ten (10) days after receipt of any PFDC Components, PFI shall deliver a certificate of receipt to the Manufacturing Department of PFDC, identifying the code and designation of the PFDC Component, the quantity received, the date of receipt and any possible reservations made to the carrier.
4.1.3 On or before the fifth (5th) business day of each month, PFI shall provide notice to PFDC that shall indicate the quantity of all PFDC Components currently held by PFI.
4.1.4 PFI shall provide PFDC and its auditors reasonable access at reasonable times to verify the quantity of PFDC Components held by PFI. Any such inspection by PDFC and its auditors shall be at the sole cost and expense of PFDC and without disruption to PFI's business operations.
4.1.5 PFI shall use commercially reasonable efforts to maintain and safeguard the PFDC Components against loss or damage; provided that as PFDC's sole remedy in the event of any difference between PFDC computer data and the PFI inventory, any such missing or damaged Components will be invoiced to PFI by PFDC at PFDC's actual cost determined in accordance with GAAP (except to the extent PFI delivered a certificate pursuant to Section 4.1.2 above with respect to any such missing or damaged Component) beyond the following authorized annual percentage losses: Raw materials: 5% Packaging items: 3% Labels: 5%
4.2 Components supplied by PFI
4.2.1 Components supplied by PFI are used to make the Products listed in Appendix 1 (Product References) (the "PF Components"). PFI undertakes to supply the PF Components without additional charge (e.g., the applicable Product prices include all such PF Component costs).
4.2.2 PFI will obtain supplies of the PF Components within the time frame and in the quantities sufficient to supply the Firm Orders in accordance with PFI's Standard Lead Times (Appendix 1). Unless otherwise instructed in writing by PFDC, PFI will purchase PF Components nec...
Supply of Components. During the term of this Agreement, DEVAX will supply SURMODICS with quantities of each Component that DEVAX wishes to have modified by SURMODICS in order to produce quantities of Modified Component. All Components shall be provided to SURMODICS at no charge. SURMODICS will apply mutually agreed coating reagents to such Component using SURMODICS’ coating techniques that have been optimized by SURMODICS for the coating of the relevant DEVAX Medical Products and which have been licensed to DEVAX under the Master License Agreement. For the avoidance of doubt, DEVAX acknowledges the following limitations with respect to the services to be provided by SURMODICS under this Agreement:
(a) SURMODICS will provide Modified Components to DEVAX in bulk quantity, not packaged for final sale by DEVAX.
(b) SURMODICS will not sterilize the Modified Components. Sterilization of the Modified Components will be performed by DEVAX in accordance with Paragraph 11(b) below.
(c) SURMODICS will not assemble multiple Modified Components to create a complete Medical Product.
Supply of Components. XXXX shall be responsible for the supply of materials (except Bulk Drug Substance) necessary for the Development of the Drug Product. [***]
Supply of Components. 3.01 For the effective term of this Agreement and subject to the terms and conditions herein contained, Seller agrees to sell to Buyer and Buyer agrees to purchase from Seller on [* * *] basis certain Components only for the purpose of the assemble of the Components and the sale of the Products by Buyer's Affiliate [* * *], solely in the manner set forth in Clause 4 hereof.
Supply of Components. Philips shall sell to WhoVision the following components for the WhoVision Products, according to a supply agreement in substantially the form of Exhibit B: capacitive fingerprint sensors, photo fingerprint sensors. The Steering Committee may review and modify the quarterly minimum quantities required of WhoVision as set forth in such supply agreement.
Supply of Components. Each party shall provide all requirements of the Manufacturing Partner for MRVT Components or Xillix Components for use in manufacturing Co-Developed Devices for commercial sale in the Field. Each party shall sell MRVT Components or Xillix Components to the Manufacturing Partner at transfer prices to be determined by the Operating Committee, but not to exceed prices granted by the parties to other customers for similar quantities. If a party determines not to provide a certain component to the Manufacturing Partner for use in manufacturing a Co-Developed Device for commercial sale in the Field, or cannot supply such component to the Manufacturing Partner, in either case for a period of six (6) months, then the parties, through mutual discussion in good faith, shall negotiate a license for the Manufacturing Partner and the non-defaulting party (the "Non-Defaulting Party") to manufacture or have manufactured such unavailable or non-supplied components, at the Non-Defaulting Party's own cost and solely for use as a component in a Co-Developed Device in the Field. Such license shall include a royalty on commercially reasonable terms and conditions, taking into account the respective performance of the parties under the Agreement and the relative investment of the parties in the Xillix Technology or the MRVT Technology, as the case may be. In the case where a party determines not to provide a component which it is then providing to the Manufacturing Partner, such party shall use reasonable efforts to continue to supply such component to the Manufacturing Partner or the other party for a period of nine (9) months or until the Manufacturing Partner or the other party determines it is able to supply such component, whichever is sooner.
